16-84177859-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001243156.2(TAF1C):​c.*1082A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.038 in 1,586,902 control chromosomes in the GnomAD database, including 1,318 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.031 ( 87 hom., cov: 32)
Exomes 𝑓: 0.039 ( 1231 hom. )

Consequence

TAF1C
NM_001243156.2 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.92

Publications

6 publications found
Variant links:
Genes affected
TAF1C (HGNC:11534): (TATA-box binding protein associated factor, RNA polymerase I subunit C) Initiation of transcription by RNA polymerase I requires the formation of a complex composed of the TATA-binding protein (TBP) and three TBP-associated factors (TAFs) specific for RNA polymerase I. This complex, known as SL1, binds to the core promoter of ribosomal RNA genes to position the polymerase properly and acts as a channel for regulatory signals. This gene encodes the largest SL1-specific TAF. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2011]
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-84177859-T-C is Benign according to our data. Variant chr16-84177859-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262932.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0307 (4677/152324) while in subpopulation NFE AF = 0.0439 (2986/68034). AF 95% confidence interval is 0.0426. There are 87 homozygotes in GnomAd4. There are 2313 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 87 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001243156.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAF1C
NM_001243156.2
MANE Select
c.*1082A>G
3_prime_UTR
Exon 15 of 15NP_001230085.2Q15572-6
DNAAF1
NM_178452.6
MANE Select
c.*18T>C
3_prime_UTR
Exon 12 of 12NP_848547.4
TAF1C
NM_005679.4
c.*1082A>G
3_prime_UTR
Exon 14 of 14NP_005670.4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAF1C
ENST00000566732.6
TSL:2 MANE Select
c.*1082A>G
3_prime_UTR
Exon 15 of 15ENSP00000455933.1Q15572-6
DNAAF1
ENST00000378553.10
TSL:1 MANE Select
c.*18T>C
3_prime_UTR
Exon 12 of 12ENSP00000367815.5Q8NEP3-1
TAF1C
ENST00000341690.10
TSL:1
c.*1082A>G
3_prime_UTR
Exon 15 of 15ENSP00000345305.6Q15572-2

Frequencies

GnomAD3 genomes
AF:
0.0308
AC:
4681
AN:
152206
Hom.:
87
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00832
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.0434
Gnomad ASJ
AF:
0.0173
Gnomad EAS
AF:
0.0396
Gnomad SAS
AF:
0.0112
Gnomad FIN
AF:
0.0285
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0439
Gnomad OTH
AF:
0.0273
GnomAD2 exomes
AF:
0.0341
AC:
8558
AN:
251152
AF XY:
0.0330
show subpopulations
Gnomad AFR exome
AF:
0.00592
Gnomad AMR exome
AF:
0.0459
Gnomad ASJ exome
AF:
0.0219
Gnomad EAS exome
AF:
0.0358
Gnomad FIN exome
AF:
0.0322
Gnomad NFE exome
AF:
0.0418
Gnomad OTH exome
AF:
0.0326
GnomAD4 exome
AF:
0.0388
AC:
55692
AN:
1434578
Hom.:
1231
Cov.:
25
AF XY:
0.0380
AC XY:
27198
AN XY:
715154
show subpopulations
African (AFR)
AF:
0.00635
AC:
209
AN:
32914
American (AMR)
AF:
0.0468
AC:
2091
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.0216
AC:
561
AN:
25976
East Asian (EAS)
AF:
0.0454
AC:
1794
AN:
39542
South Asian (SAS)
AF:
0.0121
AC:
1038
AN:
85720
European-Finnish (FIN)
AF:
0.0319
AC:
1700
AN:
53244
Middle Eastern (MID)
AF:
0.00438
AC:
25
AN:
5712
European-Non Finnish (NFE)
AF:
0.0426
AC:
46277
AN:
1087338
Other (OTH)
AF:
0.0336
AC:
1997
AN:
59448
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
2871
5741
8612
11482
14353
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1696
3392
5088
6784
8480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0307
AC:
4677
AN:
152324
Hom.:
87
Cov.:
32
AF XY:
0.0311
AC XY:
2313
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00830
AC:
345
AN:
41578
American (AMR)
AF:
0.0431
AC:
659
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
60
AN:
3468
East Asian (EAS)
AF:
0.0395
AC:
205
AN:
5190
South Asian (SAS)
AF:
0.0112
AC:
54
AN:
4828
European-Finnish (FIN)
AF:
0.0285
AC:
303
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0439
AC:
2986
AN:
68034
Other (OTH)
AF:
0.0270
AC:
57
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
235
470
705
940
1175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0360
Hom.:
166
Bravo
AF:
0.0310
Asia WGS
AF:
0.0380
AC:
132
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
not specified (1)
-
-
1
Primary ciliary dyskinesia 13 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.12
DANN
Benign
0.40
PhyloP100
-2.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2288024; hg19: chr16-84211465; COSMIC: COSV58985333; COSMIC: COSV58985333; API